Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Veracyte (VCYT) over the last 13 years, with Q3 2025 value amounting to $956000.0.

  • Veracyte's Other Working Capital Changes rose 16446.39% to $956000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $39.6 million, marking a year-over-year increase of 88696.86%. This contributed to the annual value of -$5.4 million for FY2024, which is 2487.3% down from last year.
  • According to the latest figures from Q3 2025, Veracyte's Other Working Capital Changes is $956000.0, which was up 16446.39% from $2.5 million recorded in Q2 2025.
  • Over the past 5 years, Veracyte's Other Working Capital Changes peaked at $33.2 million during Q4 2024, and registered a low of -$5.8 million during Q3 2023.
  • In the last 5 years, Veracyte's Other Working Capital Changes had a median value of $617000.0 in 2021 and averaged $1.6 million.
  • Within the past 5 years, the most significant YoY rise in Veracyte's Other Working Capital Changes was 310452.49% (2024), while the steepest drop was 87078.65% (2024).
  • Quarter analysis of 5 years shows Veracyte's Other Working Capital Changes stood at $1.4 million in 2021, then crashed by 162.23% to -$878000.0 in 2022, then fell by 25.85% to -$1.1 million in 2023, then soared by 3104.52% to $33.2 million in 2024, then tumbled by 97.12% to $956000.0 in 2025.
  • Its Other Working Capital Changes was $956000.0 in Q3 2025, compared to $2.5 million in Q2 2025 and $2.9 million in Q1 2025.